CTSF
Cathepsin F
Also known as: CATF_HUMAN, CATSF, CLN13
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UBX1
- Gene
- CTSF
- Ensembl
- ENSG00000174080
- Chromosome
- 11
- Canonical length
- 484 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Vesicles,Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system. Cathepsins generally contain a signal sequence, followed by a propeptide and then a catalytically active mature region. The very long (251 amino acid residues) proregion of the cathepsin F precursor contains a C-terminal domain similar to the pro-segment of cathepsin L-like enzymes, a 50-residue flexible linker peptide, and an N-terminal domain predicted to adopt a cystatin-like fold. The cathepsin F proregion is unique within the papain family cysteine proteases in that it contains this additional N-terminal segment predicted to share structural similarities with cysteine protease inhibitors of the cystatin superfamily. This cystatin-like domain contains some of the elements known to be important for inhibitory activity. CTSF encodes a predicted protein of 484 amino acids which contains a 19 residue signal peptide. Cathepsin F contains five potential N-glycosylation sites, and it may be targeted to the endosomal/lysosomal compartment via the mannose 6-phosphate receptor pathway. The cathepsin F gene is ubiquitously expressed, and it maps to chromosome 11q13, close to the gene encoding cathepsin W. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
484 residues, UniProt reviewed canonical sequence.
>Q9UBX1|CTSF
1 MAPWLQLLSL LGLLPGAVAA PAQPRAASFQ AWGPPSPELL APTRFALEMF NRGRAAGTRA
61 VLGLVRGRVR RAGQGSLYSL EATLEEPPCN DPMVCRLPVS KKTLLCSFQV LDELGRHVLL
121 RKDCGPVDTK VPGAGEPKSA FTQGSAMISS LSQNHPDNRN ETFSSVISLL NEDPLSQDLP
181 VKMASIFKNF VITYNRTYES KEEARWRLSV FVNNMVRAQK IQALDRGTAQ YGVTKFSDLT
241 EEEFRTIYLN TLLRKEPGNK MKQAKSVGDL APPEWDWRSK GAVTKVKDQG MCGSCWAFSV
301 TGNVEGQWFL NQGTLLSLSE QELLDCDKMD KACMGGLPSN AYSAIKNLGG LETEDDYSYQ
361 GHMQSCNFSA EKAKVYINDS VELSQNEQKL AAWLAKRGPI SVAINAFGMQ FYRHGISRPL
421 RPLCSPWLID HAVLLVGYGN RSDVPFWAIK NSWGTDWGEK GYYYLHRGSG ACGVNTMASS
481 AVVDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CTSF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 124 nTPM
- testis: 51 nTPM
- blood vessel: 49 nTPM
- basal ganglia: 47 nTPM
- cerebellum: 46 nTPM
- liver: 44 nTPM
Single-cell type
- late spermatids: 537 nCPM
- late primary spermatocytes: 296 nCPM
- melanocytes: 203 nCPM
- müller glia: 176 nCPM
- early spermatids: 148 nCPM
- ovarian stromal cells: 146 nCPM
Immune cell
- naive CD4 T-cell: 6.4 nTPM
- NK-cell: 4.7 nTPM
- memory CD8 T-cell: 4.6 nTPM
- MAIT T-cell: 4.2 nTPM
- naive CD8 T-cell: 4.1 nTPM
- gdT-cell: 3.9 nTPM
Brain region
- choroid plexus: 129 nTPM
- white matter: 118 nTPM
- spinal cord: 103 nTPM
- basal ganglia: 98 nTPM
- hypothalamus: 96 nTPM
- medulla oblongata: 96 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CTSF.
Disease | AllUniProt
Conditions CTSF is implicated in, by any mechanism.
- Ceroid lipofuscinosis, neuronal, 13 (Kufs type) (CLN13) MIM:615362
Disease | GeneticClinVar
37 pathogenic / likely-pathogenic of 321 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neuronal ceroid lipofuscinosis 13
- Neuronal ceroid lipofuscinosis
- Inborn genetic diseases
- Neurodevelopmental disorder
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antigen processing and presentation of exogenous peptide antigen via MHC class II
- proteolysis
- proteolysis involved in protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine peptidase, cysteine active site
- Peptidase C1A, papain C-terminal
- Peptidase C1A
- Cathepsin propeptide inhibitor domain (I29)
- Cysteine peptidase, histidine active site
- Papain-like cysteine peptidase superfamily
- Papain-like cysteine endopeptidase
- Papain family cysteine protease
- Cathepsin propeptide inhibitor domain (I29)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CTSF as an antibody target. Whether an autoantibody or antibody against CTSF could matter depends on whether native CTSF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CTSF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CTSF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...